{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T14:09:58Z","timestamp":1777990198033,"version":"3.51.4"},"reference-count":74,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.jfo.2012.06.016","type":"journal-article","created":{"date-parts":[[2012,10,18]],"date-time":"2012-10-18T00:57:49Z","timestamp":1350521869000},"page":"826-837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["\u0152il et maladie de Beh\u00e7et"],"prefix":"10.1016","volume":"35","author":[{"given":"M.","family":"Khairallah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ben Yahia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Kahloun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Khairallah-Ksiaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Messaoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2012.06.016_bib0005","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0190-9622(97)80318-0","article-title":"Cutaneous vasculitis in Beh\u00e7et's disease: a clinical and histopathologic study of 20\u00a0patients","volume":"36","author":"Chen","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0010","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Beh\u00e7et's disease","volume":"341","author":"Sakane","year":"1999","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jfo.2012.06.016_bib0015","series-title":"Uveitis. Fundamentals and clinical practice","author":"Nussenblatt","year":"2004"},{"key":"10.1016\/j.jfo.2012.06.016_bib0020","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/archopht.1970.00990040453009","article-title":"The rate of visual loss in Beh\u00e7et's disease","volume":"84","author":"Mamo","year":"1970","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0025","series-title":"Ocular Infection and Immunity","first-page":"663","article-title":"Beh\u00e7et's disease","author":"Mochizuki","year":"1996"},{"key":"10.1016\/j.jfo.2012.06.016_bib0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/08830189709116845","article-title":"Uveitis in Beh\u00e7et's disease","volume":"14","author":"Nussenblatt","year":"1997","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0035","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01.icu.0000247411.59213.bb","article-title":"Beh\u00e7et's disease: general concepts and recent advances","volume":"17","author":"Okada","year":"2006","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0040","series-title":"Uveitis, text and imaging","first-page":"397","article-title":"Beh\u00e7et's disease","author":"Tugal-Tutkun","year":"2009"},{"key":"10.1016\/j.jfo.2012.06.016_bib0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.eye.6702111","article-title":"Pattern of uveitis in a referral centre in Tunisia, North Africa","volume":"21","author":"Khairallah","year":"2007","journal-title":"Eye"},{"key":"10.1016\/j.jfo.2012.06.016_bib0050","series-title":"Uveitis and immunological disorders","first-page":"173","article-title":"Beh\u00e7et's disease","author":"Zierhut","year":"2005"},{"key":"10.1016\/j.jfo.2012.06.016_bib0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1076\/ocii.7.2.69.4018","article-title":"Beh\u00e7et's disease and antibody titers to various heat-shock protein 60s","volume":"7","author":"Tanaka","year":"1999","journal-title":"Ocul Immunol Inflam"},{"key":"10.1016\/j.jfo.2012.06.016_bib0060","first-page":"1045","article-title":"Maladie de Beh\u00e7et\u00a0: d\u2019Hippocrate aux antagonistes du TNF-\u03b1","volume":"4","author":"Zuber","year":"2008","journal-title":"Rev Med Suisse"},{"key":"10.1016\/j.jfo.2012.06.016_bib0065","series-title":"Uv\u00e9ite. Atlas en Ophtalmologie","first-page":"215","article-title":"Maladie de Beh\u00e7et","author":"Cochereau","year":"2009"},{"key":"10.1016\/j.jfo.2012.06.016_bib0070","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/art.1780251110","article-title":"Functional aberration of T cell subsets in patients with Beh\u00e7et's disease","volume":"25","author":"Sakane","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jfo.2012.06.016_bib0075","first-page":"535","article-title":"Endothelial nitric oxide synthase gene polymorphisms in Beh\u00e7et's disease","volume":"29","author":"Salvarani","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0080","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1055\/s-0038-1648428","article-title":"Extensive venous thrombosis in a case of Beh\u00e7et's disease associated with heterozygous protein C deficiency","volume":"67","author":"Shehto","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jfo.2012.06.016_bib0085","first-page":"1999","article-title":"\u0152il et maladie de Beh\u00e7et","volume":"49","author":"Binisti","year":"1999","journal-title":"Rev Prat"},{"key":"10.1016\/j.jfo.2012.06.016_bib0090","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/bjo.86.2.140","article-title":"The incidence and pathology of conjunctival ulceration in Beh\u00e7et's syndrome","volume":"86","author":"Matsuo","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0095","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.preteyeres.2007.09.002","article-title":"Beh\u00e7et's disease: ocular effects and treatment","volume":"27","author":"Deuter","year":"2008","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jfo.2012.06.016_bib0100","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0161-6420(97)30249-8","article-title":"Risk factor assessment and prognosis of eye involvement in Behcet's disease in Turkey","volume":"104","author":"Demiro\u011flu","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2012.06.016_bib0105","series-title":"Diagnosis and treatment of uveitis","first-page":"632","article-title":"Adamantiades-Beh\u00e7et disease","author":"Zafirakis","year":"2002"},{"key":"10.1016\/j.jfo.2012.06.016_bib0110","series-title":"Uveitis, text and imaging","first-page":"28","article-title":"Laser flare photometry","author":"Herbort","year":"2009"},{"key":"10.1016\/j.jfo.2012.06.016_bib0115","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/bjo.70.8.589","article-title":"Treatment and visual prognosis in Beh\u00e7et's disease","volume":"70","author":"Benezra","year":"1986","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0120","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","article-title":"Uveitis in Beh\u00e7et's disease: an analysis of 880\u00a0patients","volume":"138","author":"Tugal-Tutkun","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0125","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10792-008-9203-9","article-title":"Pattern of uveitis in Beh\u00e7et's disease in a referral center in Tunisia, North Africa","volume":"29","author":"Khairallah","year":"2009","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0130","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.lpm.2008.04.015","article-title":"Neurological manifestations of Behcet's disease: 22\u00a0cases among 170\u00a0patients","volume":"38","author":"Tohm\u00e9","year":"2009","journal-title":"Presse Med"},{"key":"10.1016\/j.jfo.2012.06.016_bib0135","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1034\/j.1600-0404.2003.00019.x","article-title":"A neuro-Behcet's lesion in oculomotor nerve nucleus","volume":"108","author":"Aydin","year":"2003","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jfo.2012.06.016_bib0140","first-page":"300","article-title":"Fascicular oculomotor nerve palsy in neuro-Beh\u00e7et's disease","volume":"11","author":"Saribas","year":"1991","journal-title":"J Clin Neuroophthalmol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0145","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0002-9394(14)70393-9","article-title":"Neuro-Beh\u00e7et disease presenting with internuclear ophthalmoplegia","volume":"122","author":"Masai","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0150","first-page":"147","article-title":"Neuropapillite de la maladie de Beh\u00e7et","volume":"18","author":"Gallinaro","year":"1995","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0155","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0021-5155(01)00466-X","article-title":"Optic nerve involvement in neuro-Behcet's disease","volume":"46","author":"Nakamura","year":"2002","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0160","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/092739490500264","article-title":"Myositis and scleritis associated with Behcet's disease: an atypical presentation","volume":"12","author":"Dursun","year":"2004","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jfo.2012.06.016_bib0165","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0161-6420(03)00265-3","article-title":"Conjunctival ulcers in Beh\u00e7et's disease","volume":"110","author":"Zamir","year":"2003","journal-title":"Ophtalmology"},{"key":"10.1016\/j.jfo.2012.06.016_bib0170","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/112067210201200516","article-title":"Conjunctival ulcer: mucocutaneous or ocular manifestation of Beh\u00e7et's disease? A case report","volume":"12","author":"Shenoy","year":"2002","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0175","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1442-9071.2006.01181.x","article-title":"Orbital inflammation associated with Beh\u00e7et's disease","volume":"34","author":"Hammami","year":"2006","journal-title":"Clin Experiment Ophtalmol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0180","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4103\/0301-4738.83611","article-title":"Macular hole in Beh\u00e7et's disease","volume":"59","author":"Al-Dhibi","year":"2011","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0185","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12348-012-0075-9","article-title":"Macular involvement in patients with Beh\u00e7et's uveitis","volume":"2","author":"Kahloun","year":"2012","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.jfo.2012.06.016_bib0190","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3109\/09273948.2011.650776","article-title":"Central serous chorioretinopathy, corticosteroids, and uveitis","volume":"20","author":"Khairallah","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jfo.2012.06.016_bib0195","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/09273948.2011.582219","article-title":"Branch retinal artery occlusion associated with Beh\u00e7et disease","volume":"19","author":"Ben Yahia","year":"2011","journal-title":"Ocul Imm Inflam"},{"key":"10.1016\/j.jfo.2012.06.016_bib0200","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/ard.28.2.95","article-title":"Beh\u00e7et's syndrome with arthritis","volume":"28","author":"Mason","year":"1969","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jfo.2012.06.016_bib0205","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1756-185X.2009.01455.x","article-title":"Validation of the International Criteria for Beh\u00e7et's disease (ICBD) in Iran","volume":"13","author":"Davatchi","year":"2010","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jfo.2012.06.016_bib0210","first-page":"1078","article-title":"Criteria for diagnosis of Beh\u00e7et's disease","volume":"335","author":"International Study Group for Beh\u00e7et's disease","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.jfo.2012.06.016_bib0215","first-page":"2511","article-title":"Is there a place for large vessel disease in the diagnostic criteria of Beh\u00e7et's disease?","volume":"26","author":"Schirmer","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0220","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1749-6632.2009.04756.x","article-title":"HLA-B27\u00a0and HLA-B51\u00a0determination in Tunisian healthy subjects and patients with suspected ankylosing spondylitis and Beh\u00e7et's disease","volume":"1173","author":"Sakly","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jfo.2012.06.016_bib0225","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.revmed.2009.04.014","article-title":"Ocular manifestations of Beh\u00e7et's disease","volume":"31","author":"Saadoun","year":"2010","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jfo.2012.06.016_bib0230","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/ard.57.11.694","article-title":"Increased erythrocyte aggregation as an indicator for an aggressive clinical course in Beh\u00e7et's disease: a prospective study","volume":"57","author":"Demiro\u011flu","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jfo.2012.06.016_bib0235","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3346\/jkms.1993.8.4.241","article-title":"Clinical study on death in Behcet's disease","volume":"8","author":"Park","year":"1993","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jfo.2012.06.016_bib0240","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3129\/i08-080","article-title":"Beh\u00e7et's disease comparing three decades of treatment response at the National Eye Institute","volume":"43","author":"Kump","year":"2008","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0245","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/art.1780400425","article-title":"Azathioprine in Behcet's syndrome: effects on long-term prognosis","volume":"40","author":"Hamuryudan","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jfo.2012.06.016_bib0250","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/eye.1998.203","article-title":"The role of azathioprine in the management of retinal vasculitis","volume":"12","author":"Greenwood","year":"1998","journal-title":"Eye"},{"key":"10.1016\/j.jfo.2012.06.016_bib0255","first-page":"136","article-title":"Evaluation of conventional therapy versus cyclosporine A in Behcet's syndrome","volume":"20","author":"Benezra","year":"1988","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jfo.2012.06.016_bib0260","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1034\/j.1600-0420.1998.760118.x","article-title":"Cyclosporin A therapy in severe uveitis of Beh\u00e7et's disease","volume":"76","author":"S\u00fcll\u00fc","year":"1998","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.jfo.2012.06.016_bib0265","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/bjo.76.4.241","article-title":"Low dose cyclosporine A versus pulsed cyclophosphamide in Beh\u00e7et's syndrome: a single masked trial","volume":"76","author":"Ozzyazgan","year":"1992","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0270","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1442-9071.2001.00445.x","article-title":"Central nervous system symptoms in a population of Beh\u00e7et's disease patients with refractory uveitis treated with cyclosporine A","volume":"29","author":"Kato","year":"2001","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0275","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0161-6420(99)90120-3","article-title":"Central nervous system symptoms in patients with Beh\u00e7et disease receiving cyclosporine therapy","volume":"106","author":"Kotake","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2012.06.016_bib0280","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1053\/sarh.2001.19819","article-title":"Treatment of Beh\u00e7et's disease: an update","volume":"30","author":"Kaklamani","year":"2001","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jfo.2012.06.016_bib0285","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H","article-title":"A double-blind trial of colchicine in Behcet's syndrome","volume":"44","author":"Yurdakul","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jfo.2012.06.016_bib0290","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.ajo.2008.08.038","article-title":"Long-term efficacy and safety of low dose interferon alpha-2a therapy in severe uveitis associated with Beh\u00e7et disease","volume":"146","author":"Gueudry","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0295","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/bjo.87.4.423","article-title":"Human recombinant interferon alfa-2a for the treatment of Beh\u00e7et's disease with sight threatening posterior or panuveitis","volume":"87","author":"K\u00f6tter","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0300","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.ophtha.2009.11.022","article-title":"Safety and effectiveness of interferon alpha-2a in treatment of patients with Beh\u00e7et's uveitis refractory to conventional treatments","volume":"117","author":"Sobaci","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2012.06.016_bib0305","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.berh.2004.02.008","article-title":"Beh\u00e7et's disease","volume":"18","author":"Marshall","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0310","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/ard.2004.028498","article-title":"The utility of tumour necrosis factor blockade in orphan diseases","volume":"63","author":"Keystone","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jfo.2012.06.016_bib0315","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/rheumatology\/kem034","article-title":"Anti-TNF therapy in the management of Behcet's disease. Review and basis for recommendations","volume":"46","author":"Sfikakis","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.jfo.2012.06.016_bib0320","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0161-6420(03)00406-8","article-title":"Infliximab in the treatment of refractory posterior uveitis","volume":"110","author":"Joseph","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2012.06.016_bib0325","first-page":"98","article-title":"Short-term trial of etanercept in Behcet's disease: a double-blind, placebo controlled study","volume":"32","author":"Melikoglu","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0330","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/bjo.2009.158840","article-title":"Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Beh\u00e7et disease","volume":"94","author":"Yamada","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0335","first-page":"S133","article-title":"Efficacy of infliximab and adalimumab in the treatment of a patient with severe neuro-Beh\u00e7et's disease","volume":"26","author":"Belzunegui","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0340","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/ICU.0b013e3282f03d42","article-title":"Biologics in the treatment of uveitis","volume":"18","author":"Imrie","year":"2007","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0345","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/rheumatology\/keg424","article-title":"Remission induction in Beh\u00e7et's disease following lymphocyte depletion by the anti-CD52\u00a0antibody Campath-1H","volume":"42","author":"Lockwood","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.jfo.2012.06.016_bib0350","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1136\/bjo.85.11.1287","article-title":"Intravenous immunoglobulin therapy for resistant ocular Beh\u00e7et's disease","volume":"85","author":"Seider","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0355","first-page":"1437","article-title":"Complete regression of retinal neovascularisation after therapy with interferon alfa in Beh\u00e7et's disease","volume":"84","author":"St\u00fcbiger","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2012.06.016_bib0360","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/ard.2007.080432","article-title":"EULAR recommendations for the management of Beh\u00e7et's disease","volume":"67","author":"Hatemi","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jfo.2012.06.016_bib0365","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1167\/iovs.09-4769","article-title":"Evaluation of experimental autoimmune uveitis in mice treated with FTY720","volume":"51","author":"Commodaro","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2012.06.016_bib0370","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/annrheumdis-2011-155143","article-title":"Interleukin-1\u03b2-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study","volume":"71","author":"G\u00fcl","year":"2012","journal-title":"Ann Rheum Dis"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018155121200277X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S018155121200277X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:03:28Z","timestamp":1759259008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S018155121200277X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":74,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S018155121200277X"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2012.06.016","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u0152il et maladie de Beh\u00e7et","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2012.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}